IL21R hypomethylation as a biomarker for distinguishing benign and malignant breast tumours

IL21R hypomethylation as a biomarker for distinguishing benign and malignant breast tumours

Some benign and malignant breast tumours are similar in pathological morphology, which are difficult to be distinguished in clinical diagnosis. In this study, we intended to explore novel biomarkers for differential diagnosis of benign and malignant breast tumours. Methylation EPIC 850K beadchip and...

Full description

Saved in:
Bibliographic Details
Main Authors: Zishan Zang, Yifei Yin, Chunlan Liu, Qiang Zhu, Xuandong Huang, Hong Li, Rongxi Yang
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Epigenetics
Subjects:
Breast cancer
benign breast tumours
differential diagnosis
DNA methylation
IL21R gene
biomarker
Online Access:https://www.tandfonline.com/doi/10.1080/15592294.2024.2352683
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/15592294.2024.2352683

Similar Items